MiR-23a in amplified 19p13.13 loci targets metallothionein 2A and promotes growth in gastric cancer cells

Journal of Cellular Biochemistry

Volumn 114, Issue 9, 2013, Pages 2160-2169

  An, Juan ^a,b   Pan, Yuanming ^a   Yan, Zhi ^a   Li, Wenmei ^a   Cui, Jiantao ^a   Yuan, Jiao ^c   Tian, Liqing ^c   Xing, Rui ^a   Lu, Youyong ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b QINGHAI UNIVERSITY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

COPY NUMBER VARIATION; GASTRIC CANCER; miR 23a; MT2A

Indexed keywords

METALLOTHIONEIN II; MICRORNA; MIR 23A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CANCER CELL; CANCER GROWTH; CARCINOGENICITY; COPY NUMBER VARIATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCUS; GENE TARGETING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 84880470198     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24565     Document Type: Article

References (30)

1. Ambros V,. 2004. The functions of animal microRNAs. Nature 431: 350-355.
2. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM,. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004.
3. Chhabra R, Dubey R, Saini N,. 2010. Cooperative and individualistic functions of the microRNAs in the miR-23a-27a-24-2 cluster and its implication in human diseases. Mol Cancer 9: 232.
4. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, Aerts J, Andrews TD, Barnes C, Campbell P, Fitzgerald T, Hu M, Ihm CH, Kristiansson K, Macarthur DG, Macdonald JR, Onyiah I, Pang AW, Robson S, Stirrups K, Valsesia A, Walter K, Wei J, Tyler-Smith C, Carter NP, Lee C, Scherer SW, Hurles ME,. 2010. Origins and functional impact of copy number variation in the human genome. Nature 464: 704-712.
5. Cui Y, Wang J, Zhang X, Lang R, Bi M, Guo L, Lu SH,. 2003. ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis. Biochem Biophys Res Commun 302: 904-915.
6. Esquela-Kerscher A, Slack FJ,. 2006. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
7. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM,. 2005. A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
8. Huang S, He X, Ding J, Liang L, Zhao Y, Zhang Z, Yao X, Pan Z, Zhang P, Li J, Wan D, Gu J,. 2008. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer 123: 972-978.
9. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C,. 2004. Detection of large-scale variation in the human genome. Nat Genet 36: 949-951.
10. Janssen AM, van Duijn W, Oostendorp-Van DRM, Kruidenier L, Bosman CB, Griffioen G, Lamers CB, van Krieken JH, van De Velde CJ, Verspaget HW,. 2000. Metallothionein in human gastrointestinal cancer. J Pathol 192: 293-300.
11. Kim JM, Sohn HY, Yoon SY, Oh JH, Yang JO, Kim JH, Song KS, Rho SM, Yoo HS, Kim YS, Kim JG, Kim NS,. 2005. Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin Cancer Res 11: 473-482.
12. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR,. 2005. MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
13. Manikandan J, Aarthi JJ, Kumar SD, Pushparaj PN,. 2008. Oncomirs: The potential role of non-coding microRNAs in understanding cancer. Bioinformation 2: 330-334.
14. Marcinkowska M, Szymanski M, Krzyzosiak WJ, Kozlowski P,. 2011. Copy number variation of microRNA genes in the human genome. BMC Genomics 12: 183.
15. Micci F, Skotheim RI, Haugom L, Weimer J, Eibak AM, Abeler VM, Trope CG, Arnold N, Lothe RA, Heim S,. 2010. Array-CGH analysis of microdissected chromosome 19 markers in ovarian carcinoma identifies candidate target genes. Genes Chromosomes Cancer 49: 1046-1053.
16. Morohara K, Tajima Y, Nakao K, Nishino N, Aoki S, Kato M, Sakamoto M, Yamazaki K, Kaetsu T, Suzuki S, Tsunoda A, Tachikawa T, Kusano M,. 2006. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: Association with E-cadherin expression and chromosomal changes. J Cancer Res Clin Oncol 132: 363-375.
17. Or YY, Chung GT, To KF, Chow C, Choy KW, Tong CY, Leung AW, Hui AB, Tsao SW, Ng HK, Yip TT, Busson P, Lo KW,. 2010. Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma. J Pathol 220: 97-107.
18. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, Yoshida Y, Seto M,. 2004. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64: 3087-3095.
19. Perry GH, Dominy NJ, Claw KG, Lee AS, Fiegler H, Redon R, Werner J, Villanea FA, Mountain JL, Misra R, Carter NP, Lee C, Stone AC,. 2007. Diet and the evolution of human amylase gene copy number variation. Nat Genet 39: 1256-1260.
20. Pezzolo A, Capra V, Raso A, Morandi F, Parodi F, Gambini C, Nozza P, Giangaspero F, Cama A, Pistoia V, Garre ML,. 2008. Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma. Cancer Lett 261: 235-243.
21. Pinkel D, Albertson DG,. 2005. Array comparative genomic hybridization and its applications in cancer. Nat Genet 37 (Suppl): S11-S17.
22. Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS,. 2010. A census of amplified and overexpressed human cancer genes. Nat Rev Cancer 10: 59-64.
23. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C, Tyler-Smith C, Carter N, Scherer SW, Tavare S, Deloukas P, Hurles ME, Dermitzakis ET,. 2007. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315: 848-853.
24. Ting AH, McGarvey KM, Baylin SB,. 2006. The cancer epigenome-Components and functional correlates. Genes Dev 20: 3215-3231.
25. Ushijima T,. 2005. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5: 223-231.
26. Vauhkonen H, Vauhkonen M, Sajantila A, Sipponen P, Knuutila S,. 2006. DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridization. Cancer Genet Cytogenet 167: 150-154.
27. Wu MC, Zhang L, Wang Z, Christiani DC, Lin X,. 2009. Sparse linear discriminant analysis for simultaneous testing for the significance of a gene set/pathway and gene selection. Bioinformatics 25: 1145-1151.
28. Yang S, Jeung HC, Jeong HJ, Choi YH, Kim JE, Jung JJ, Rha SY, Yang WI, Chung HC,. 2007. Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer. Genomics 89: 451-459.
29. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'Brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos G,. 2006. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103: 9136-9141.
30. Zhu LH, Liu T, Tang H, Tian RQ, Su C, Liu M, Li X,. 2010. MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. FEBS J 277: 3726-3734.